TrialAdvances in therapy2020

Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend Regimens in Exudative Age-Related Macular Degeneration: 52- and 96-Week Findings from ALTAIR : A Randomized Controlled Trial.

Masahito Ohji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.